Results 111 to 120 of about 20,345 (260)

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

StudyonCreepPropertiesandConstitutiveModelofThenardite

open access: yes工程科学与技术, 2015
:To study creep properties of thenardite,triaxial compression creep tests to thenardite specimens were carried out on the RLW-2000 rock rheology testing machine.The test results indicated that the creep strain and steady creep rate of thenardite ...
王军保   +3 more
doaj  

Creep characteristics of muddy siltstone and its engineering application on cross-river tunnel stability

open access: yesScientific Reports
Muddy siltstone combines the characteristics of both sandstone and mudstone, and is prone to instability over time. To study the long-term stability of tunnel engineering in this stratum, this article taking the cross-river metro tunnel section as the ...
Huijuan Deng   +5 more
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

The Establishment of a Rock Creep Model by Using Creep Bodies via an Improved Gene Expression Programming Algorithm

open access: yesApplied Sciences
Rock creep commonly appears in rock mass engineering, and it should be paid appropriate attention. In this paper, studies on creep constitutive models of rocks were reviewed, and it was found that the types of creep constitutive models can generally be ...
Pingyang Fan   +6 more
doaj   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy